Gatti, Milo; Bartoletti, Michele; Cojutti, Pier Giorgio; Gaibani, Paolo; Conti, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2021, 27, pp. 294 - 298 [Scientific article]Open Access
Gatti M.; Cojutti P.G.; Campoli C.; Caramelli F.; Corvaglia L.T.; Lanari M.; Pession A.; Ramirez S.; Viale P.; Pea F., A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 755075 , pp. 1 - 13 [Scientific article]Open Access
Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections, «ANTIBIOTICS», 2021, 10, Article number: 1311 , pp. 1 - 12 [Scientific article]Open Access
Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6”, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 833 - 834 [Scientific article]
Cojutti P.G.; Gatti M.; Rinaldi M.; Tonetti T.; Laici C.; Mega C.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 781892 , pp. 1 - 11 [Scientific article]Open Access
Rinaldi, Matteo; Cojutti, Pier Giorgio; Zamparini, Eleonora; Tedeschi, Sara; Rossi, Nicolò; Conti, Matteo; Giannella, Maddalena; Pea, Federico; Viale, Pierluigi, Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2021, 65, Article number: 02038-20 , pp. 1 - 14 [Scientific article]Open Access
Cojutti P.G.; Carnelutti A.; Lazzarotto D.; Sozio E.; Candoni A.; Fanin R.; Tascini C.; Pea F., Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles?, «PHARMACEUTICS», 2021, 13, Article number: 2099 , pp. 1 - 13 [Scientific article]Open Access
Cojutti P.G.; Morandin E.; Baraldo M.; Pea F., Population pharmacokinetics of continuous infusion of piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against Enterobacterales and Pseudomonas aeruginosa, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2021, 58, Article number: 106408 , pp. 1 - 9 [Scientific article]
Cojutti, Pier Giorgio; Rinaldi, Matteo; Zamparini, Eleonora; Rossi, Nicolò; Tedeschi, Sara; Conti, Matteo; Pea, Federico; Viale, Pierluigi, Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2021, 65, Article number: e02260-20 , pp. 1 - 13 [Scientific article]Open Access
Cojutti, Pier Giorgio; Zanon, Ezio; Pasca, Samantha; Pea, Federico, Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency, «CLINICAL PHARMACOKINETICS», 2021, na, pp. 1 - 12 [Scientific article]
Cojutti P.G.; Rinaldi M.; Gatti M.; Tedeschi S.; Viale P.; Pea F., Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2021, 58, Article number: 106445 , pp. 1 - 3 [Scientific article]
Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6, «CLINICAL PHARMACOKINETICS», 2020, 59, pp. 1251 - 1260 [Scientific article]Open Access
Cojutti P.G.; Lazzarotto D.; Candoni A.; Dubbini M.V.; Zannier M.E.; Fanin R.; Pea F., Real-Time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: Results from a prospective, monocentric, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2020, 75, pp. 3029 - 3037 [Scientific article]Open Access
Cojutti, Pier Giorgio; Maximova, Natalia; Schillani, Giulia; Hope, William; Pea, Federico, Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 1648 - 1655 [Scientific article]
Cojutti P.G.; Merelli M.; Bassetti M.; Pea F., Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: Findings from a monocentric, prospective, open-label, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 3588 - 3595 [Scientific article]
